Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer

被引:4
|
作者
Nakamura, Naoki [1 ]
Hojo, Hidehiro [1 ]
Inoue, Kazuya [2 ]
Hotta, Kenji [1 ]
Zenda, Sadamoto [1 ]
Baba, Hiromi [1 ]
Onozawa, Masakatsu [1 ]
Motegi, Atsushi [1 ]
Nakamura, Masaki [1 ]
Kibe, Yuichi [1 ]
Akimoto, Tetsuo [1 ]
机构
[1] Natl Canc Ctr Hosp East, Div Radiat Oncol & Particle Therapy, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan
[2] Takai Hosp, Dept Radiol, 470-8 Kuranosho, Tenri, Nara 6320006, Japan
关键词
lung cancer; radiation therapy; proton beam therapy; radiological change; STEREOTACTIC ABLATIVE RADIOTHERAPY; BODY RADIATION-THERAPY; MASS-LIKE CONSOLIDATION; INJURY; RECURRENCE; SBRT;
D O I
10.1093/jrr/rry028
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study aimed to examine late radiological changes after proton beam therapy (PBT) for early-stage non-small cell lung cancer (NSCLC) and to clarify correlations between mass-like radiological changes and patient characteristics. CT scans of patients who underwent passive scattering PBT for T1-2N0M0 NSCLC were analyzed retrospectively. Patients were considered eligible if follow-up CT was performed for at least 2 years, with no definite evidence of local recurrence. The following five periods were defined: (i) 6-12 months, (ii) 12-24 months, (iii) 24-36 months, (iv) 36-48 months and (v) 48-60 months after PBT. Late (>= 6 months) radiological changes were scored by consensus of three radiation oncologists according to classifications set forth by Koenig (Radiation injury of the lung after three-dimensional conformal radiation therapy. AJR Am J Roentgenol 2002; 178: 1383-8.). CT scans of 113 patients (median follow-up, 36 months; range, 24-137 months) were evaluated. Late radiological changes during Periods (i), (ii), (iii), (iv) and (v) included modified conventional pattern (80%, 79%, 72%, 58% and 56%, respectively), mass-like changes (8%, 9%, 14%, 22% and 18%, respectively), scar-like changes (4%, 9%, 11%, 17% and 24%, respectively) and no increased density (8%, 3%, 3%, 2% and 2%, respectively). Mass-like changes were observed in 23 patients (20%). Among patients who developed mass-like changes, the median interval between the initiation of PBT and the onset of mass-like changes was 19 months (range, 6-62 months). In multivariate analysis, a peripheral location was found to be a significant factor (P = 0.035; odds ratio: 4.44; 95% confidence interval: 1.12-21.28). In conclusion, mass-like changes were observed in 20% of patients who underwent PBT. Patients with peripheral tumors showed a higher incidence of mass-like changes.
引用
收藏
页码:456 / 461
页数:6
相关论文
共 50 条
  • [41] Late recurrence after resection of stage I lung adenocarcinoma
    Kikuchi, N
    Satoh, H
    Sekizawa, K
    Ishikawa, S
    ANNALS OF THORACIC SURGERY, 2003, 75 (03): : 1069 - 1070
  • [42] Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer
    Takada, Akinori
    Nakamura, Tatsuya
    Takayama, Kanako
    Makita, Chiyoko
    Suzuki, Motohisa
    Azami, Yusuke
    Kato, Takahiro
    Tsukiyama, Iwao
    Hareyama, Masato
    Kikuchi, Yasuhiro
    Daimon, Takashi
    Toyomasu, Yutaka
    Ii, Noriko
    Nomoto, Yoshihito
    Sakuma, Hajime
    Fuwa, Nobukazu
    CANCER MEDICINE, 2016, 5 (03): : 506 - 515
  • [43] LATE RADIOLOGICAL CHANGES AFTER STEREOTACTIC ABLATIVE RADIOTHERAPY OF PRIMARY LUNG TUMORS
    Dahele, Max
    Palma, David
    Lagerwaard, Frank J.
    Slotman, Ben
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S543 - S543
  • [44] High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors
    Makita, Chiyoko
    Nakamura, Tatsuya
    Takada, Akinori
    Takayama, Kanako
    Suzuki, Motohisa
    Azami, Yusuke
    Kato, Takahiro
    Tsukiyama, Iwao
    Hareyama, Masato
    Kikuchi, Yasuhiro
    Daimon, Takashi
    Hata, Masaharu
    Inoue, Tomio
    Fuwa, Nobukazu
    ACTA ONCOLOGICA, 2015, 54 (03) : 307 - 314
  • [45] High-dose Proton Beam Therapy and Carbon-ion Radiotherapy for Stage I Non-small-cell Lung Cancer
    Iwata, H.
    Murakmi, M.
    Miyawaki, D.
    Terashima, T.
    Niwa, Y.
    Demizu, Y.
    Akagi, T.
    Hishikawa, Y.
    Shibamoto, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S59 - S59
  • [46] Clinical Outcomes of Proton Beam Therapy for Stage I Lung Cancer in Patients with Interstitial Pneumonia: A Multi-Institutional Retrospective Study in Japan
    Tokumaru, S.
    Ohnishi, K.
    Harada, H.
    Wada, H.
    Nakamura, N.
    Arimura, T.
    Iwata, H.
    Sato, Y.
    Tamamura, H.
    Ogino, H.
    Ogino, T.
    Akimoto, T.
    Okimoto, T.
    Kikuchi, Y.
    Murayama, S.
    Sakurai, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E93 - E93
  • [47] Outcomes and Prognostic Factors for Recurrence After High-Dose Proton Beam Therapy for Centrally and Peripherally Located Stage I None-Small-Cell Lung Cancer
    Kanemoto, Ayae
    Okumura, Toshiyuki
    Ishikawa, Hitoshi
    Mizumoto, Masashi
    Oshiro, Yoshiko
    Kurishima, Koichi
    Homma, Shinsuke
    Hashimoto, Takayuki
    Ohkawa, Ayako
    Numajiri, Haruko
    Ohno, Toshiki
    Moritake, Takashi
    Tsuboi, Koji
    Sakae, Takeji
    Sakurai, Hideyuki
    CLINICAL LUNG CANCER, 2014, 15 (02) : E7 - E12
  • [48] Salvage Therapy for Relapse after Stereotactic Body Radiation for Stage I Lung Cancer
    Oaks, Z. A.
    Bogart, J.
    Nsouli, T.
    Aridgides, P.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1575 - S1576
  • [49] Monte Carlo Dose Verification of Passive Scattering Proton Therapy for Prostate Cancer
    Giantsoudi, D.
    Paganetti, H.
    MEDICAL PHYSICS, 2012, 39 (06) : 3819 - 3819
  • [50] Lung Density Changes After Proton Therapy for Lung Tumors: Can Dose Constraints for Photon Therapy be Applied to Proton Therapy?
    Murai, T.
    Muramatsu, R.
    Omachi, C.
    Iwata, H.
    Nakajima, K.
    Toshito, T.
    Hayashi, K.
    Ogino, H.
    Shibamoto, Y.
    Mizoe, J. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E483 - E483